Bank wealth managers churn out same products under series numbers

Walk into any Chinese bank branch or open its mobile app, and you will see a parade of wealth management products with nearly identical names, differing only by a trailing series number. WMP Series No. 123, Series No. 124, Series No. 125 — each one a carbon copy of the last. This is not a glitch in the system. It is a deliberate strategy. Chinese banks issue these identical products in numbered sequences to manage returns with surgical precision. Each tranche shares the same investment strategy, the same distribution channel, and the same underlying asset pool. The only difference is the launch date and the reported net value. For the investor, the choice is an illusion. For the bank, the series is a tool. The mechanism is straightforward. When a product in a series underperforms, the bank can quietly roll its assets into a new tranche with a fresh start date. The new series number resets the performance clock. Older, weaker returns are buried under a wave of newer, better-looking numbers. The bank’s overall wealth management performance metrics stay smooth, even when the market turns choppy. Regulators have taken notice. The practice of “chart-topping” — manufacturing a top-quartile product by issuing many clones and letting the best-performing one stand out — has drawn scrutiny. The central bank and financial regulators have issued guidelines aimed at curbing such tactics. They want transparency, not sleight of hand. Yet the serial issuance persists. It is not a secret. It is a structural feature of a market where banks compete fiercely on wealth management rankings, and where investors have been conditioned to chase the highest reported returns. A single product with a stellar number can lift an entire series’ reputation, even if the underlying performance is average. What a casual reader might miss is the risk concentration. Because these series share the same investment strategy, a downturn in a specific asset class — say, real estate bonds or local government financing vehicles — can hit dozens of tranches simultaneously. The series structure masks that correlation. An investor holding Series No. 124 may think they are diversified, but they are not. The regulatory push has not stopped the practice, but it has forced banks to become more creative. Some now issue products with slightly different maturity dates or fee structures, just enough to claim they are distinct. Others have shifted to open-ended products that can be repriced daily, avoiding the need for numbered series altogether. The real test will come when credit conditions tighten further. If defaults rise, the series structure will reveal its weakness: a cascade of identical products all hitting their trigger points at once. The banks that have leaned hardest on serial issuance may find themselves with a portfolio of lookalike losses, not lookalike winners. That is a problem no new series number can solve.

Chinese banks issue identical wealth management products in numbered series to manage returns. Many tranches share the same investment strategy and distribution channel.

Serial issuance lets wealth managers smooth performance metrics, a practice that persists despite regulatory scrutiny on chart-topping tactics.

The development adds to a wider China financial services story in which companies are being judged on execution, capital access, regulatory fit and the credibility of their regional expansion plans.

For business readers, the important question is whether this becomes an isolated announcement or part of a more durable operating pattern across customers, financing channels, partners and public-market expectations.